Fi3 Financial Advisors’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69.9K | Buy |
24,172
+202
| +0.8% | +$584 | 0.03% | 165 |
|
|
2025
Q1 | $51.5K | Buy |
23,970
+172
| +0.7% | +$370 | 0.02% | 134 |
|
|
2024
Q4 | $92.1K | Buy |
23,798
+3,411
| +17% | +$13.2K | 0.03% | 121 |
|
|
2024
Q3 | $134K | Hold |
20,387
| – | – | 0.05% | 111 |
|
|
2024
Q2 | $148K | Sell |
20,387
-5,061
| -20% | -$36.7K | 0.07% | 83 |
|
|
2024
Q1 | $198K | Hold |
25,448
| – | – | 0.09% | 84 |
|
|
2023
Q4 | $116K | Sell |
25,448
-123
| -0.5% | -$560 | 0.06% | 73 |
|
|
2023
Q3 | $101K | Buy |
25,571
+23
| +0.1% | +$91 | 0.05% | 71 |
|
|
2023
Q2 | $80K | Hold |
25,548
| – | – | 0.04% | 69 |
|
|
2023
Q1 | $116K | Hold |
25,548
| – | – | 0.06% | 76 |
|
|
2022
Q4 | $106K | Sell |
25,548
-74,022
| -74% | -$306K | 0.06% | 70 |
|
|
2022
Q3 | $319K | Sell |
99,570
-22,248
| -18% | -$71.3K | 0.29% | 32 |
|
|
2022
Q2 | $239K | Hold |
121,818
| – | – | 0.2% | 43 |
|
|
2022
Q1 | $493K | Hold |
121,818
| – | – | 0.38% | 24 |
|
|
2021
Q4 | $1.31M | Hold |
121,818
| – | – | 0.86% | 19 |
|
|
2021
Q3 | $1.41M | Hold |
121,818
| – | – | 0.93% | 17 |
|
|
2021
Q2 | $1.22M | Buy |
121,818
+100,570
| +473% | +$1.01M | 0.84% | 18 |
|
|
2021
Q1 | $310K | Buy |
+21,248
| New | +$310K | 0.27% | 34 |
|